Lifeway Foods, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023, compared with FY2022. This is an annual report; the supplied filing text does not provide standalone fourth-quarter results. Dollar amounts below are in millions unless stated otherwise.
Business context and financial performance
Lifeway produces and sells cultured dairy products, led by drinkable kefir. It reported one operating segment. Drinkable kefir excluding ProBugs generated $127.7 million, or 80% of sales; cheese contributed $13.8 million, or 9%.
| Metric | FY2023 | FY2022 |
|---|---|---|
| Net sales | $160.1 | $141.6 |
| Gross profit / margin | $42.4 / 26.5% | $26.8 / 18.9% |
| Operating income / margin | $17.0 / 10.6% | $2.3 / 1.7% |
| Net income / net margin | $11.4 / 7.1% | $0.9 / 0.7% |
| Diluted EPS | $0.75 | $0.06 |
| Cash from operations | $16.9 | $4.0 |
Sales rose 13.1%, primarily on higher branded drinkable-kefir volumes and, to a lesser extent, price increases implemented in late 2022. Gross margin improved mainly from higher branded-product volumes, favorable milk pricing and lower transportation costs; the company also cited the benefit of price increases. Operating expenses increased to $25.4 million from $24.4 million. The effective tax rate was 31.7%, down from 49.1%.
Cash, debt and liquidity
- Cash and cash equivalents were $13.2 million at year-end, up from $4.4 million. Current assets were $38.2 million and current liabilities $16.6 million.
- Operating cash flow was $16.9 million; investing cash outflow was $4.4 million, including $4.35 million of property and equipment purchases; financing cash outflow was $3.8 million.
- Year-end debt was $2.75 million gross on the term loan ($2.73 million net of financing costs); the $5 million revolving facility was undrawn, with $5 million available. The company repaid its $2.78 million line-of-credit balance in October 2023.
- The term loan bears interest at SOFR plus 2.07%; its reported year-end rate was 6.29%. The company reported compliance with debt covenants. No dividends were declared or paid in 2023 or 2022.
Management commentary, outlook and risks
Management said inflationary pressures moderated in 2023, including lower conventional milk prices, and that it had not experienced significant supply-chain or labor shortages. It described liquidity as sufficient for operating needs, capital requirements and growth initiatives, but provided no quantified revenue, earnings or margin guidance. Planned capital spending focuses on growth, cost reduction and facility improvements.
Key risks include competition and retailer pricing pressure; volatile milk and other input costs; reliance on key customers, suppliers, co-packers and a limited number of facilities; food safety, regulatory and product-liability exposure; and cybersecurity or supply-chain disruption. Two customers represented approximately 24% of 2023 sales and 25% of year-end receivables. Variable-rate debt and covenant requirements create additional financial risks. The filing also describes Danone’s shareholder-agreement rights and the Smolyansky family’s ability to influence shareholder matters.
The company reported no material goodwill impairment in 2023 and no legal accruals material individually or in aggregate, while noting adverse litigation outcomes could have an adverse effect. The independent auditor issued an unqualified opinion and reported no critical audit matters. Management concluded internal control over financial reporting was effective; the filing states the company was not required to obtain, and the auditor was not engaged to perform, an audit of internal controls.
Important facts for investors to verify
- International sales disclosure: The business discussion says sales distributed outside the U.S. were approximately 2% of 2023 net sales, while the financial-statement note says sales outside the U.S. were less than 1%. Reconcile this difference.
- Profit improvement: Assess how much of the 2023 margin expansion reflects recurring volume and cost conditions versus price increases and favorable milk pricing.
- Customer concentration: Review the identities, commercial terms and continued purchasing trends of the two customers representing about 24% of sales.
- Liquidity and debt: Monitor cash conversion, planned capital spending, term-loan repayments, variable interest costs and covenant compliance.
- Governance and dilution: Review Danone and family-related rights, equity-compensation plans and potential effects on strategic transactions and shareholders.